Sphingotec announces new data on the kidney function marker proenkephalin (penKid®) presented at 24th International Conference on Advances in Critical Care Nephrology.

March 18, 2019

Learn more

Endothelial disruption: Rapid translation from bench to bedside.

Jan. 25, 2019

Learn more

Sphingotec raises €20 million from HBM and Wellington Partners.

October 8, 2018

Learn more

Sphingotec is adding an advanced POC testing platform to portfolio

May 22, 2018

Learn more